BIOHEALTH

Impact BioMedical Logo.png
sweet.png

See More

Lab Experiment
Impact BioMedical Logo.png

Independently Valued at:

US$ 933 Million

Based on the effective ownership of the technologies by Impact BioMedical

Current Products

MOSQUITO TECHNOLOGY

Functional Fragrance Formulation (“3F”)

US$ 62 Mil

A suite of functional fragrances developed for industrial and medical applications

PANDEMIC RESEARCH

Equivir

US$ 79 Mil

A patented OTC medication with broad antiviral activity

LINEBACKER PLATFORM

Linebacker

US$ 922 Mil

Broad-spectrum universal therapeutic platform

ALTERNATIVE SUGAR

Laetose

US$ 259Mil

Natural functional sugar

NEW CLASS OF MEDICINAL CHEMISTRY

Quantum

A new frontier in pharmaceutical development.

ADVANCED PLASTICS

BioPlastics

Advanced  plastics that break down into bio-digestible fragments

Upcoming Projects

BIODEFENSE APPLICATION

Nanoparticle Applications

Prevention and mitigation of life threatening pandemics

THERAPEUTIC MEDICAL FOODS

Medical Food

Treatment and management of Neurological Disorders, Diabetes, Metabolic Syndrome, Bacterial and Viral Infection.

United States    Canada    London   Australia   Singapore   Hong Kong   China   Japan   Malaysia   Taiwan   Philippines   Israel   Spain

© 2020 Alset International Ltd.